期刊文献+

光子刀治疗恶性肿瘤207例临床研究 被引量:1

Photo knife for cancer:an study of 207 patients
下载PDF
导出
摘要 目的:观察分析光子刀在肿瘤放疗中的应用情况及技术特点,以进一步指导临床实践。方法:总结207例光子刀治疗的恶性肿瘤患者的靶区部位、治疗方针、治疗计划设计(计划靶体积、剂量分割、照射方式)、实施方法及不良反应。结果:照射部位:头颈部49例、体部158例。靶区分布前三位分别是:肺(24.6%)、颅脑(14.5%)和肝(13.5%)。治疗方针:单纯放疗190例(根治103例、姑息87例)和缩野推量17例。治疗计划:计划靶体积(PTV):1~246.5cm3,中位值66.7cm3。射野数目:2~11个,中位数目6个。照射剂量:单次分割剂量1.2~9.56Gy,中位剂量6Gy;总量12~70Gy,中位剂量48Gy。分割方式:每周5次190例,每周(5次17例;分割次数:3~30次,中位数9次。不良反应:全组共发生16例1~2级放射不良反应(RTOG/EORCT标准),占7.7%,无3级以上不良反应发生。结论:高精度、高剂量、高疗效和低损伤是光子刀治疗的临床优势,"小而精"的剂量学特点是优势形成的关键因素,推荐计划靶体积(PTV)≤216cm3,临床以单放和常规分割照射为主的方式较为常用且安全,应用范围广并可望成为胰腺癌新的治疗选择,但摆位误差等问题亟待解决。 Objective:In order to further improve the clinical project the clinical application and technical character of photon knife in cancer treatment was observed and analyzed. Methods:The target position, treatment choice and planning (target volume,dose and fractionation) , implementation and side-effect of 207 patients suffered from different cancers treated by photon knife were summarized. Results:Irradiation position: head and neck 49 ,body 158. The first three target position were lung (24. 6% ) , encephalocoele (14. 5% ) and liver (13.5%) respectively, radiotherapy alone 190(radical 103, palliative 87), and 17 cases as boost. Dose-fraction: single dose 1.2-9. 56Gy, median 6Gy; total dose: 12-70Gy, median 48Gy; dose fractionation: 5/W for 190, 〈 5/W for 17; fraction :3-30, median 9 ; irradiation fields 2-11, median 6 ; planning target volume (PTV) : 1-246cm^3 , median 66. 7cm^3 ; side-effect : 1-2 grade side-effect of radiation(RTOG/EORTC) was found in 16 cases(7.7% ) , without any side-effect over 3 grade in total cases. Conclusion :The clinical advantage of Photon knife are being more accuracy ,dosage and effect but less damage. The dosage character of "small and accuracy" is the key factor and PTV ≤216cm^3 is recommended. The application of radiation alone and 5/W fraction is usual and safe. The photon knife can be used widely in clinical and would even become a new choice for pancreatic carcinoma, but the error of position setting should be solved.
出处 《临床肿瘤学杂志》 CAS 2007年第8期591-594,共4页 Chinese Clinical Oncology
关键词 光子刀 肿瘤 剂量优势 计划靶体积 Photon knife Neoplasms Dosage advantage Planning target volume(PTV)
  • 相关文献

参考文献12

二级参考文献34

  • 1董永华,林贵.大鼠肝癌肝动脉碘油柱塞后的门脉血供[J].中华放射学杂志,1994,28(9):582-584. 被引量:34
  • 2[1]Hopper KD,Singapurii K,Fingkel A.Body CT and oncologic imaging[J].Radiology,2000,215:27-40.
  • 3[2]Sweeney DJ,Low VH,Robbins PD,et al.Calcified lymph node metastases in adenocarcinoma of the colon[J].Australian Radiol,1994,38:233-234.
  • 4[3]Perring S,Hind R,Fleming J,et al.Dosimetric assessment of radiolabelled lipiodol as a potential therapeutic agent in colorectal liver metastases using combined CT and SPECT[J].Nucl Med Commun,1994,15:34-38.
  • 5[4]Prerez CA,Pajak TF,Rubin P.Long-term observation of the patients of failure in patients with unresected non-small cell cacinoma with definitive radiotherapy:report by the RTOG[J].Cancer,1987,59:1874-1881.
  • 6Danato V, Zudo A, Bonftli P, et al. Hypofracionaled radiation therapy for inoperable advanced stage non-small cell lung cancer[J]. Tumori,1999,85(3) : 174-176.
  • 7Chien CR, Chen SW, Hsieh CY, et al. Intra-thoracic failure pattern and survival status following 3D conformal radiotherapy for non-small cell lung cancer: a preliminary report[J]. Jpn J Clin Oncol,2001,31(2) :55-60.
  • 8Sibley GS, Jamieson TA, Marks LB, et 81. Radiotherapy alone for medically inoperable stage Ⅰ non small-cell lung cancer: The duke experience[J]. Int J Radiat Oncol Biol Phys,1998, 40(1) : 149-154.
  • 9Segawa Y, Takigawa N, Kataoka M. Risk factors for development of radiation pneumonitis following radiation therapy with or without chemotherapy for lung cancer[J].Int J Radiat Oncol Biol Phys,1997 , 39(1) : 91-98.
  • 10Mouson J, Stark J, Sugarbaker D, et 81. Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma[J]. Cancer,1998,82(5) : 842-850.

共引文献24

同被引文献3

  • 1Stinchcombe TE, Socinski MA. Current treatments for advanced stage non-small cell lung cancer[J].Proc Am Thorac Soc, 2009, 6(2) :233-241.
  • 2Cohen MH, Justice R, Pazdur R. Approval summary: pemetrexed in the initial treatment of advanced/metastatic non-small cell lung cancer[ J]. Oncologist, 2009, 14(9) :930-935.
  • 3钟巍,赵静,张晓彤,张力,王孟昭,李龙芸.培美曲赛单药治疗晚期非小细胞肺癌的疗效与安全性[J].中华内科杂志,2010,49(8):671-674. 被引量:8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部